中文名稱  凝血酶(凝血因子II)激活肽2抗體費(fèi)用 

英文名稱  Anti-Thrombin Activation peptide fragment 2

別    名 Activation peptide fragment 2; coagulation factor II; prothrombin; F2; Cf-2; Cf2; FII; F 2; coagulation factor II (thrombin); Coagulation factor II; Coagulation factor II precursor; F2; Factor II; Factor-II; Prothrombin; prothrombin B-chain; PT; serine protease; THRB; THRB_HUMAN; Thrombin.

產(chǎn)品屬性：

凝血酶(凝血因子II)激活肽2抗體費(fèi)用 濃    度  1mg/1ml

規(guī) 格  0.1ml/100μg 0.2ml/200μg

抗體來源  Rabbit

克隆類型   polyclonal

交叉反應(yīng)   Human, Mouse, Rat, Guinea Pig

產(chǎn)品類型   一抗  

研究領(lǐng)域    心 細(xì)胞生物 激酶和磷酸酶 合成與降解

蛋白分子量  predicted molecular weight: 14/64kDa 

性    狀   Lyophilized or Liquid

免 疫 原  KLH conjugated synthetic peptide derived from human Thrombin Activation peptide fragment 2

亞    型  IgG

純化方法   affinity purified by Protein A

儲(chǔ) 存 液   Preservative: 15mM Sodium Azide, Constituents: 1% BSA, 0.01M PBS, pH 7.4

凝血酶(凝血因子II)激活肽2抗體費(fèi)用 產(chǎn)品應(yīng)用   WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500

（石蠟切片需做抗原修復(fù)） 

 not yet tested in other applications.

 optimal dilutions/concentrations should be determined by the end user.  

保存條件  Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C. 

Important Note  This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications. 

產(chǎn)品介紹 Thrombin is the final protease in the blood coagulation cascade and serves both pro- and anticoagulant functions through the cleavage of several targets. The ability of thrombin to specifically recognize a wide range of substrates derives from interactions which occur outside of the active site of thrombin. Thrombin possesses two anion binding exosites which mediate many of its interactions with cofactors and substrates, and although many structures of thrombin have been solved, few such interactions have been described in molecular detail. Glycosaminoglycan binding to exosite II of thrombin plays a major role in switching off the procoagulant functions of thrombin by mediating its irreversible inhibition by circulating serpins and by its binding to the endothelial cell surface receptor thrombomodulin.

Function : Thrombin is an active enzyme in the earliest steps of the blood clot formation, generated from its circulating inactive precursor prothrombin. Thrombin is a glycoprotein formed by two peptides chains of 36 and 259 amino acids linked by disulfure bonds. Three important sites have been identified on the surface of the enzyme: The catalytic site that confers to the molecule its serine protease activity, the exosite one responsible for the binding of the substrate (fibrinogen or thrombin receptor) and the exosite two responsible for the binding of antithrombin III and inactivation of thrombin. Gamma Thrombin is a proteolyzed form of Alpha Thrombin. Gamma Thrombin consists of four chains (A, B1, B5, B4) with a disulfide link between the A peptide and the B5 peptide.

Subunit : Heterodimer (named alpha-thrombin) of a light and a heavy chain; disulfide-linked. Forms a heterodimer with SERPINA5.

Subcellular Location : Secreted, extracellular space.

Tissue Specificity : Expressed by the liver and secreted in plasma.

Post-translational modifications : The gamma-carboxyglutamyl residues, which bind calcium ions, result from the carboxylation of glutamyl residues by a microsomal enzyme, the vitamin K-dependent carboxylase. The modified residues are necessary for the calcium-dependent interaction with a negatively charged phospholipid surface, which is essential for the conversion of prothrombin to thrombin.

N-glycosylated. N-glycan heterogeneity at Asn-121: Hex3HexNAc3 (minor), Hex4HexNAc3 (minor) and Hex5HexNAc4 (major). At Asn-143: Hex4HexNAc3 (minor) and Hex5HexNAc4 (major).

DISEASE : Factor II deficiency (FA2D) [MIM:613679]: A very rare blood coagulation disorder characterized by mucocutaneous bleeding symptoms. The severity of the bleeding manifestations correlates with blood factor II levels. Note=The disease is caused by mutations affecting the gene represented in this entry.

Ischemic stroke (ISCHSTR) [MIM:601367]: A stroke is an acute neurologic event leading to death of neural tissue of the brain and resulting in loss of motor, sensory and/or cognitive function. Ischemic strokes, resulting from vascular occlusion, is considered to be a highly complex disease consisting of a group of heterogeneous disorders with multiple genetic and environmental risk factors. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.

Thrombophilia due to thrombin defect (THPH1) [MIM:188050]: A multifactorial disorder of hemostasis characterized by abnormal platelet aggregation in response to various agents and recurrent thrombi formation. Note=The disease is caused by mutations affecting the gene represented in this entry. A common genetic variation in the 3-prime untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increased risk of venous thrombosis.

Pregnancy loss, recurrent, 2 (RPRGL2) [MIM:614390]: A common complication of pregnancy, resulting in spontaneous abortion before the fetus has reached viability. The term includes all miscarriages from the time of conception until 24 weeks of gestation. Recurrent pregnancy loss is defined as 3 or more consecutive spontaneous abortions. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.

Similarity : Belongs to the peptidase S1 family.

Contains 1 Gla (gamma-carboxy-glutamate) domain.

Contains 2 kringle domains.

Contains 1 peptidase S1 domain.

Database links : UniProtKB/Swiss-Prot: P00734.2

實(shí)驗(yàn)流程：

全、新、優(yōu)、品、好四大特點(diǎn)：

凝血酶(凝血因子II)激活肽2抗體費(fèi)用 全：公司提供上萬種產(chǎn)品，涵蓋了生物試劑，elisa試劑盒，標(biāo)準(zhǔn)品，培養(yǎng)基，原裝耗材，抗體、培養(yǎng)基、ATCC細(xì)胞等，基本上各種科研所需產(chǎn)品在我司都能找到。

新：產(chǎn)品更新速度較快，基本上每周都有新產(chǎn)品出現(xiàn)。

優(yōu)：產(chǎn)品質(zhì)量好，投訴比較少。

好：我公司具有優(yōu)質(zhì)的技術(shù)團(tuán)隊(duì)，產(chǎn)品一旦售出，實(shí)驗(yàn)過程中遇到困難可提供在線技術(shù)咨詢。使您使用產(chǎn)品時(shí)沒有任何的后顧之憂。

技術(shù)外包服務(wù):

★凝血酶(凝血因子II)激活肽2抗體費(fèi)用 分子生物學(xué)：質(zhì)粒抽提、PCR、Q-PCR、RT-PCR、分子生物學(xué)：基因合成、引物合成、基因測(cè)序、載體構(gòu)建等

★蛋白工程：原核、哺乳動(dòng)物蛋白表達(dá)系統(tǒng)等

★病毒包裝：腺病毒、慢病毒等

★抗體工程：磁珠分選、病理染色、WB、ELISA、IP、IF、IHC、FACS、Confocal等等

★細(xì)胞工程：細(xì)胞表型分析(凋亡、增殖、周期、遷移、侵襲、修復(fù)、克隆形成)、細(xì)胞培養(yǎng)、細(xì)胞膜制備、穩(wěn)定細(xì)胞株構(gòu)建、細(xì)胞RNAi技術(shù)等等。

正在熱銷的相關(guān)產(chǎn)品：

Anti-TNF- Alpha /HRP 辣根過氧化物酶標(biāo)記鼠抗人壞死因子-α單克隆抗體IgGMulti-class antibodies規(guī)格： 0.2ml

PLGF (Placenta growth factor) 胎盤生長因子(多肽抗原)Multi-class antibodies規(guī)格： 0.5mg

腱糖蛋白-C抗體 anti-Tn-C 0.2ml

5HT1E Receptor 英文名稱： 5-羥色胺受體1E抗體 0.2ml

EMR1 英文名稱： 表皮生長因子樣激素受體1 0.2ml

Rhesus antibody Rh Phospho-JunB (Thr102/Thr104) 磷酸化活化蛋白激酶B抗體 規(guī)格 0.2ml

PLGF (Placenta growth factor) 胎盤生長因子(多肽抗原)Multi-class antibodies規(guī)格： 0.5mg

Anti-TIMP-4/FITC 熒光素標(biāo)記金屬蛋白酶組織抑制因子-4抗體IgGMulti-class antibodies規(guī)格： 0.2ml

NOS-2 (iNOS) Nitric Oxide Synthase,Inducible 合成酶-2(抗原)Multi-class antibodies規(guī)格： 0.5mg

三碘甲狀腺素T3抗體 Anti-T3 0.2ml

SSX8 英文名稱： 滑膜X斷點(diǎn)蛋白8抗體 0.1ml

Phospho-Estrogen Receptor alpha (Ser118) 英文名稱： 磷酸化雌激素受體α抗體 0.1ml

Rhesus antibody Rh phospho-LRP5(Thr1492) 磷酸化受體相關(guān)蛋白5抗體 規(guī)格 0.1ml

NOS-2 (iNOS) Nitric Oxide Synthase,Inducible 合成酶-2(抗原)Multi-class antibodies規(guī)格： 0.5mg

CD63/MLA1 溶酶體膜糖蛋白抗原Multi-class antibodies規(guī)格： 0.5mg

Anti-Bag1/RAP46 抑凋亡基因bag1抗體Multi-class antibodies規(guī)格： 0.1ml

Rhesus antibody Rh Phospho-A Raf(Ser299) 磷酸化A-Raf抗體 規(guī)格 0.1ml

Ki67 濃縮液 0.1ml 進(jìn)口分裝

UBE2J2 英文名稱： 泛素蛋白連接酶J2抗體 0.2ml

CHST12 英文名稱： 碳水化合物磺基轉(zhuǎn)移酶12抗體 0.1ml

Anti-Bag1/RAP46 抑凋亡基因bag1抗體Multi-class antibodies規(guī)格： 0.1ml

IL7 Protein Human 重組人 IL7 / ierleukin 7 蛋白

胰蛋白酶(含100mL 酶解緩沖液) 10mL

HA Others H4N8 甲型 H4N8 (A/chicken/Alabama/1/1975) 血凝素HA1 (Hemagglutinin) 人細(xì)胞裂解液 (陽性對(duì)照)

FaDu人咽鱗癌細(xì)胞 FaDu human pharyngeal squamous cell carcinoma MEM(GIBCO)+10%FBS

CM-H027人淋巴成纖維細(xì)胞完全培養(yǎng)基100mL

人人(HEK-a) ( 5×105 ) 小鼠成纖維細(xì)胞(EGFP標(biāo)記) Mouse

CM-H089人髂動(dòng)脈內(nèi)皮細(xì)胞完全培養(yǎng)基100mL

IFNA13 Others Cynomolgus 食蟹猴 IFNA13 / Ierferon alpha-13 人細(xì)胞裂解液 (陽性對(duì)照)

人腸微內(nèi)皮細(xì)胞HIMEC

HS68細(xì)胞，人男性正常細(xì)胞系 大鼠嗜堿性粒細(xì)胞性細(xì)胞,RBL-1細(xì)胞 平滑肌細(xì)胞培養(yǎng)基SMCM

MC3T3-E1 Subclone 14(小鼠顱頂前骨細(xì)胞亞克隆14) 5×106cells/瓶×2

AGS(人胃腺癌細(xì)胞) 5×106cells/瓶×2 CM-R051大鼠子宮頸上皮細(xì)胞完全培養(yǎng)基100mL 人上皮樣細(xì)胞;BEAS-2B

凝血酶(凝血因子II)激活肽2抗體費(fèi)用 IL7 Protein Human 重組人 IL7 / ierleukin 7 蛋白

胰蛋白酶(含100mL 酶解緩沖液) 10mL

HA Others H4N8 甲型 H4N8 (A/chicken/Alabama/1/1975) 血凝素HA1 (Hemagglutinin) 人細(xì)胞裂解液 (陽性對(duì)照)

FaDu人咽鱗癌細(xì)胞 FaDu human pharyngeal squamous cell carcinoma MEM(GIBCO)+10%FBS

CM-H027人淋巴成纖維細(xì)胞完全培養(yǎng)基100mL

人人(HEK-a) ( 5×105 ) 小鼠成纖維細(xì)胞(EGFP標(biāo)記) Mouse